HOME
ABOUT US
OUR COMPANY
OUR TEAM
BOARD OF DIRECTORS
INVESTORS
CAREERS
T-GUARD®
CHARACTERISTICS
DEVELOPMENT PLAN
GRAFT-VERSUS-HOST
ADDITIONAL INDICATIONS
EXPANDED ACCESS
A PATIENT’S STORY
NEWS & EVENTS
NEWS
EVENTS
IN THE MEDIA
PUBLICATIONS
PARTNERING
PARTNERING FOR PROGRESS
CONTACT
✕
2015
Filter by
Languages
Skill level
Authors
Show all
All
Press-releases
All
2021
2019
2018
2017
2016
2015
2014
2013
2012
All
MauriceHampsink
1 oktober 2015
1 oktober 2015
Clinical Study of T-Guard® in the Treatment of GVHD extends to Germany
15 september 2015
15 september 2015
Announcement Maarten Frijlink as Company’s Chief Operating Office
